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Abstract  
Background: Evidence for risks of adverse maternal and birth outcomes in women with 
hyperemesis gravidarum (HG) is predominantly from small studies, unknown or conflicting. 
Methods: A population-based cohort study using secondary healthcare records (Hospital 
Episode Statistics covering all of England from 1997-2012) was used to calculate odds ratios 
(OR) with 99% confidence intervals (CI) for the association between HG hospital admission 
and adverse outcomes, adjusting for maternal and pregnancy confounders. 
Results: Within 8,211,850 pregnancies ending in live births or stillbirths, women with HG 
had increased odds of anaemia (OR 1.28, 99% CI 1.23,1.33), preeclampsia (OR 1.16, 99%CI 
1.09,1.22),  eclampsia (OR 1.84, 99% CI 1.07,3.18), venous thromboembolism antenatally 
(OR 1.94, 99% CI 1.57,2.39 for deep vein thrombosis and OR 2.54, 99% CI 1.89,3.40 for 
pulmonary embolism) and post-partum. Odds of stillbirth (OR 0.77, 99% CI 0.66,0.89) and 
post-term (OR 0.86, 99% CI 0.81,0.92) delivery were decreased. Women were more likely to 
be induced (OR 1.20, 99% CI 1.16,1.23), to deliver preterm (OR 1.11, 99% CI 1.05,1.17), very 
preterm (OR 1.18, 99% CI 1.05,1.32) or by caesarean section (OR 1.12, 99% CI 1.08,1.16),  to 
have low birthweight (OR 1.12, 99% CI 1.08,1.17) or small-for-gestational-age (OR 1.06, 99% 
CI 1.01,1.11) babies and, although absolute risks were small, their offspring were more likely 
to undergo resuscitation or neonatal intensive care. 
Conclusion: HG may have important antenatal and postnatal consequences that should be 
considered in communications between healthcare professionals and women  to best 
manage HG and prevent progression during pregnancy. 
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Introduction 
Hyperemesis gravidarum (HG) is the most severe form of nausea and vomiting in pregnancy 
(NVP) and in many cases requires hospital admission and continuous treatment. 1 It affects 
up to 2% of pregnancies, causing other maternal and child morbidities responsible for 
further hospital admissions and adverse social, psychological and economic impacts in 
affected women.2 In England in 2010 alone, HG was the primary diagnosis for over 17,500 
hospital admissions in pregnancy.3 While maternal dehydration,1,4,5 weight loss and 
anaemia1 are the most evident consequences of HG, severe NVP can also trigger central 
nervous system complications,4 liver and renal failure,6 and antenatal venous thrombosis 
(VTE).7 There is some evidence of a higher risk of placental dysfunction and preeclampsia8 in 
women first admitted with HG in the second trimester, whilst associations with 
complications such as gestational diabetes and hypertension9–11 or postnatal VTE12,13 are 
less clear. There is conflicting evidence on how HG may directly affect the health of the 
unborn child in terms of birthweight or being small for gestational age. Although some 
studies suggest that HG is not associated with adverse pregnancy outcomes,9,10 others have 
found associations with preterm birth14 and lower birthweight15,16. Moreover, little evidence 
has been reported on the occurrence of stillbirth8 and need for neonatal care for babies 
born to women affected by HG. The burden of HG likely remains grossly underestimated by 
the medical community5 and urgent calls for large population studies on this topic have 
been raised.17  
We assessed the risk of adverse maternal, pregnancy and birth outcomes for women 
admitted to hospital for HG, using a cohort of over 8 million pregnancies identified from 
anonymised electronic hospital records in England. Outcomes investigated included 
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stillbirth, low birthweight, preterm birth and delivery complications for both the mother and 
the baby. 
 
Materials and Methods 
Study population 
A cohort of pregnancies was built by extracting data on each delivery recorded in the English 
maternity Hospital Episode Statistics (HES) dataset between April 1997 and March 2011, 
including only pregnancies ending in live birth or stillbirth, as previously described.3 A 
probabilistic matching algorithm was used to link a mother’s delivery record to one or more 
children’s birth records. A hierarchical approach used the following 6 variables in a priority 
order: delivery date, unique hospital identifier, postcode of residence, unique general 
practice identifier, gestational age at birth and birthweight. Overall 86.3% of the total HES 
pregnancies were matched to one or more children. Of the matched pregnancies, 32.1% had 
a unique match to children on all variables, providing the highest degree of certainty; 
inability to match on all variables was mainly due to missing information primarily for 
gestation or birthweight in either the mother or child’s record. The following 57.2% were 
matched on 4-5 variables. The remaining 10.7% were matched with the minimum 
requirement of the first 3 variables, still providing a robust assumption. Whilst our 
probability matching algorithm will have a margin of error we expect this to be small and 
this is a standard approach with routinely-collected anonymised datasets for health 
research.18,19 HES data are anonymised such that individual patients as well as the location 
of residence cannot be identified by researchers. Ethical approval for this study was 
obtained from The Health & Social Care Information Centre (DSA Reference: DARS-NIC-
25516-N5Q7T) 
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Hyperemesis gravidarum 
A pregnancy was considered affected by HG if at least one admission with an ICD-10 code 
(International Classification of Diseases version 10, used to define diagnoses) for HG (O210 
or O211) was recorded as the primary diagnosis, excluding admissions on the date of  
delivery, in line with a previous published study.3 Pregnancies with a first admission for HG 
in the third trimester were excluded as HG usually peaks at 8 weeks’ gestation and a later 
first admission could be a misdiagnosis of other pregnancy complications such as 
preeclampsia or acute fatty liver of pregnancy.8 We grouped women as having only one HG 
admission during pregnancy (i.e., HG admission), having at least one re-admission (i.e., HG 
readmission) or no HG admissions during pregnancy.  
 
Adverse maternal, pregnancy and birth outcomes 
Outcomes were selected based on the literature9,14,17 and availability in HES data. Maternal 
and pregnancy outcomes included birth status (live birth or stillbirth); gestational age at 
delivery grouped as very preterm (24-31 weeks), preterm (32-36 weeks), term (37-41 
weeks) and post-term (over 42 weeks); type of delivery (spontaneous, assisted or breech 
extraction, emergency or elective caesarean section); haemorrhage (ante, intra and post-
partum); induction of labour (surgical, medical, both, unspecified); placental dysfunction 
(malformation, praevia, abruption); anaemia occurring after the first trimester; pre-
eclampsia (with or without eclampsia); gestational diabetes; gestational hypertension; and 
venous thromboembolism (VTE) during pregnancy, at delivery and in the first 12 weeks 
postpartum, distinguishing between deep vein thrombosis (DVT) and pulmonary embolism 
(PE). Delivery and postpartum VTE analysis without history within the current pregnancy or 
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delivery was also assessed to distinguish a first event from (previously treated) recurrences. 
The recorded prevalence of delivery type was comparable to published HES statistics 20 and 
other published work. 21  Comorbidities were extracted from diagnostic codes according to 
ICD-10 code lists and relevant procedures (e.g. caesarean section) from OPCS-4 codes 
(Office of Population Censuses and Surveys Classification of Interventions and Procedures, 
used to define procedures). The maternity HES dataset provided information whenever 
missing from the two previous sources. This priority reflects the ordered level of data 
quality, where procedure recording is expected to have the highest accuracy due to the 
original purpose of hospital data recording. Gestational age at birth, birthweight, neonatal 
care and resuscitation are only available from maternity HES. 
 
Live births or stillbirths were obtained mainly from recorded diagnoses (97.5% for live 
outcomes and 97% for stillbirths) and then from maternity HES. Induction of labour was 
obtained in a priority order from recorded information on procedures from OPCS-4 used 
during delivery (85%) which were largely in agreement with the maternity HES dataset 
(except for surgical induction which was underreported in maternity HES), recorded ICD-
codes (0.6%) and maternity HES (14%).  
 
We assessed the following adverse birth outcomes among live matched singletons: need for 
neonatal care (special, intensive and very intensive); resuscitation method (drugs, drugs and 
mask, tube, tube and drugs); birthweight (<2500, 2500-3999 and ≥4000 g). Small or large 
for gestational age (SGA/LGA), defined as less than the 10th centile and more than the 90th 
centile respectively, were estimated using the Global Reference standard that accounts for 
mean differences in birthweight by maternal race. 22,23 
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Potential confounding factors identified a priori were those previously shown to be 
associated with HG as well as with adverse maternal and neonatal outcomes.3 They were 
year of delivery, English region of secondary care setting, maternal age, parity, ethnicity, 
socio-economic group as measured by quintile of the Index of Multiple Deprivation (IMD 
2010), maternal comorbidities (anaemia, thyroid and parathyroid dysfunctions, 
hypercholesterolemia, pre-existing diabetes or hypertension), sex of the baby and birth 
plurality. Details and methods to obtain these factors are described elsewhere.3 
 
Statistical analysis 
We calculated the percentage of pregnancies affected by HG hospital admission and 
readmission (as a proportion of all pregnancies) and assessed variation across different 
values of each outcome. For the binary outcomes gestational anaemia, diabetes and 
hypertension, we performed logistic regression to estimate odds ratios (OR) with 99% 
confidence intervals (CI) for the associations with HG admission and HG readmission, both 
compared with a baseline of no admission. As all other maternal, pregnancy or birth 
outcomes had 3 or more possibilities (e.g., low, normal or high birthweight), we used 
multinomial logistic regression with the relative risk ratio (RRR) option in Stata to produce 
similar effect measures. The RRR is sometimes interpreted as a conditional odds ratio or 
called a multinomial odds ratio and so for the purposes of this paper we report model 
output as an OR from here forward.  We applied a cluster correction to all analyses to 
account for potential clustering effects from women who had more than one pregnancy 
during the study period. Analyses were adjusted for maternal confounders and different 
sets of relevant outcomes other than the outcome under analysis, depending on the time of 
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onset of the factor and the potential confounding effect that those outcomes could have in 
each risk assessment analysis. Table 1 shows the list of covariate factors for each analysis.  
Missing values for gestational age groups (32%) were imputed using an ordered logistic 
regression imputation method in Stata MPv14 (Stata Corp, College Station, TX) statistical 
package, with 10 imputed datasets and the predictor variables in Table 2. Sensitivity analysis 
was also conducted excluding all pregnancies with missing information. A similar method 
was used to impute small or large for gestational age. 
 
Results 
We obtained a cohort of 8,211,850 pregnancies from 5,329,101 women, where 0.53% (n= 
43,766) of pregnancies ended in stillbirth, and 1.6% (n= 130,138) were multiple deliveries 
(Table 2). The prevalence of HG admission and readmission was 1.02% (n=83,679) and 
0.42% (n=34,518), respectively. The prevalence showed that hospital admission and 
readmission for HG were more common in women under the age of 30, of Black or Asian 
ethnicity, with higher socio-economic deprivation, carrying multiple babies or a female 
baby, and with pre-existing anaemia, thyroid or parathyroid dysfunction, 
hypercholesterolemia or type 1 diabetes in the current pregnancy.  
 
Table 3 shows the numbers, proportions and adjusted odds ratios for each adverse maternal 
outcome for women with one HG admission and HG readmission, compared to women 
without HG admissions. Compared with women from the referent group, women with one 
admission for HG had an increased relative odds of developing anaemia, preeclampsia and 
eclampsia during the current pregnancy. These women also showed an increased relative 
odds of antepartum VTE for DVT and for PE, VTE recorded during the delivery admission (OR 
10 
 
2.11, 99% CI 1.37,3.26 for DVT) and postpartum VTE (OR 1.49, 99% CI 1.03,2.14 for DVT and 
OR1.61, 99% CI 1.08,2.38 for PE). A generally higher relative odds was shown for women 
with more than one admission for HG, particularly for antepartum DVT (OR 2.64, 99% CI 
2.00,3.48) and delivery and postpartum PE (OR 3.47, 99% CI 1.53,7.89 and OR1.92, 99% CI 
1.11,3.34 respectively). Confidence intervals of effect estimates overlapped between HG 
admission and readmission for most outcomes, other than for anaemia and gestational 
hypertension, the odds of which were both significantly higher for HG readmission. 
 
Although the odds ratios for preeclampsia and VTE were high for admitted women, the 
absolute increased risks were generally low (absolute risks of preeclampsia were 2.2%, 2.7% 
and 3.1% in women without HG admission, with HG admission and with readmission 
respectively; for antepartum DVT absolute risks were 9, 18 and 25 per 10,000 pregnancies 
respectively; for postpartum DVT absolute risks were 4, 6 and 7 per 10,000 pregnancies 
respectively). 
 
The adjusted analysis for adverse delivery outcomes (Table 4) showed a decreased relative 
odds of stillbirth (OR 0.77, 99% CI 0.66, 0.89), in pregnancies affected by a single admission 
for HG. There was not significant variation for haemorrhage and placental dysfunction, 
though elective caesarean section and induction of labour were more likely in women with 
HG (OR 1.12, 99% CI 1.08,1.16 for caesarean section, OR 1.20, 99% CI 1.16,1.23 for surgical 
and medical induction). Although the analyses of HG readmission were affected by limited 
statistical power, the results described above were largely similar. 
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The prevalence of HG admission and readmission and the distribution of maternal 
characteristics within the 6,835,060 singleton pregnancies were the same as for the whole 
population shown in Table 2, indicating that the restricted matched population was not 
different from the original one. The risk of adverse birth outcome also varied between 
women with and without HG (Table 5). Women with a single admission for HG were more 
likely to deliver very preterm (OR 1.18, 99% CI 1.05,1.32), preterm birth (OR1.11, 99% CI 
1.05,1.17) and less likely to deliver post-term (OR 0.90, 99% CI 0.85,0.96). The relative odds 
of neonates being in need of resuscitation with drugs or drugs and mask, and intensive 
neonatal care were also higher (OR 1.13, 99% CI 1.05,1.21, OR 1.19, 99% CI 1.06,1.33 and OR 
1.18, 99% CI 1.04,1.33 respectively) however the absolute increased risks were generally 
low. Moreover, babies from pregnancies affected by HG were more likely to have a low 
birthweight (<2500 gr) and to be small for gestational age (OR 1.12, 99% CI 1.08,1.17 and OR 
1.06, 99% CI 1.01,1.11 respectively) compared to children from the referent group. They 
were also less likely to have a high birthweight (≥4000 g) (OR 0.88, 99% CI 0.85,0.91). 
 
Excluding pregnancies with missing data on gestational age, resulted in a distribution of 
gestational age and birthweight categories more similar to those from national statistics. 
Reassuringly the findings relating to HG, however, showed very similar relative odds for 
adverse neonatal outcomes to the overall analysis (Table S1). 
 
Comment 
12 
 
Main findings 
We assessed the risk of adverse maternal, delivery and birth outcomes in women with one 
or more hospital admissions with a primary diagnosis of HG using the full inpatient hospital 
records dataset for England (HES) collected from 1997 to 2012. Within a cohort of over 8 
million pregnancies we found that hospital admission for HG was associated with a relative 
increase of developing anaemia, preeclampsia and eclampsia, hypertension during 
pregnancy and DVT and PE antenatally, at delivery and up to 12 weeks postpartum. Women 
with HG admissions were more likely to be induced, have a caesarean section and deliver 
preterm. Although the relative odds of stillbirth was reduced for women with HG 
admissions, their babies were more likely to be small for gestational age and have low 
birthweight.  
 
Interpretation 
While a general association between HG and preeclampsia has been previously reported,34 
another large study 8 found that women with a first admission for HG in the second 
trimester were more likely to develop preeclampsia. We found that this association was 
true also for eclampsia and for both HG admission and readmission, regardless of the time 
of admission. Although we had no evidence that HG is responsible for minor placental 
dysfunctions, it could be an early warning of severe problems associated with placental 
function such as eclampsia or the two conditions could share a common aetiology reflecting 
for instance different aspects of faulty immunology of pregnancy. 
 
The Royal College of Obstetricians and Gynaecologists’ (RCOG) green-top guidelines 
consider HG a transient risk factor for VTE27 according to evidence of a general increased 
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risk of VTE for women with HG.7,35 However, while a higher VTE risk during the antepartum 
period and at delivery was confirmed in other studies,7,12 evidence for VTE in the post-
partum period alone was not reported.12,13 Whilst the absolute risk was very small, in our 
study women with HG showed a higher relative odds of VTE antenatally, at delivery and up 
to 12 weeks post-partum for both DVT and PE. This could be due to an ante-partum DVT 
either diagnosed only postnatally or causing a later postpartum PE. Clinical reviews and 
previous studies1,36 have shown anaemia as a likely consequence of HG due to malnutrition 
and this was confirmed by our results. The current largest study on the topic so far14 showed 
an inverse association with large for gestational age (OR 0.95, [0.90,99]), in agreement with 
our results (OR 0.97, 99% CI 0.93,0.99 and OR 0.92, 99% CI 0.87,0.98 respectively) although 
we found a positive association with very preterm birth, in contrast with their results. In 
addition we showed an increased relative odds of SGA especially for HG readmission, as 
confirmed by other studies. 8,17 We found HG to be significantly associated with preterm 
birth and low birthweight, which was also confirmed in a previous systematic review.17 
 
Of the very few studies that have looked into the risk of stillbirth for women with HG, lack of 
statistical power was a common limitation even for the largest of these.9,10,14 In contrast, 
our study population size allowed us to show an inverse association with stillbirth in 
agreement only with a previous study from 1985.37 This finding is somewhat counter-
intuitive; the risk of SGA is increased in women with HG (probably due to placental 
dysfunction or maternal nutritional deficits), and SGA is known to be one of the main causes 
of stillbirth.38 A possible explanation is that the increased rate of spontaneous and elective 
preterm deliveries among women with HG outweighs this effect, such that the children at 
the greatest risk of stillbirth if carried to term are typically delivered before they become 
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fatally malnourished, leading to a lower risk of stillbirth overall. We did not find any 
association between HG and gestational diabetes and contrasting results are reported in 
previous studies.9–11 HG was not a risk factor for gestational hypertension in previously 
published work,9,10 in contrast with our results showing higher effect estimates for HG 
readmission. Higher rates of induction of labour and caesarean section have been 
demonstrated previously in women with HG,39 in agreement with our results; however for 
the nature of our data we were unable to establish why these medical interventions were 
chosen by the doctor. Children born to mothers with HG were also more likely to need 
neonatal care and/or resuscitation although the absolute increased risks were low; this is to 
our knowledge the first study to look into these specific adverse outcomes. 
 
Strengths of the study. 
To our knowledge this work represents the largest study so far carried out on this topic. The 
quality of the HES dataset has improved over time24 and its validity has been demonstrated 
in different studies including in the area of perinatal epidemiology.3,21 Over 97% of deliveries 
in England and Wales in the 1997-2011 time window took place in National Health Service 
(NHS), maternity units and maternity wings25 and all delivery information is recorded in 
inpatient data. Moreover, in the UK, all women are offered free antenatal care and entitled 
to free NHS prescriptions during pregnancy therefore we believe that our population 
capture the vast majority of pregnant women in the UK. The data are comprehensive, 
nationally representative,21,26–29 and prospectively recorded so free from recall bias. The size 
of our population and the assessment of significance at the 1% level reduce the possibility 
that results were due to chance alone.  
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Limitations of the data 
Although data on some possible confounding factors, such as smoking or body mass index 
(BMI), weight loss or treatment, were not available, information on a large number of other 
basic demographic characteristics and common comorbidities allowed for a robust 
adjustment for important confounders. Hospital data will miss milder complications, such as 
mild anaemia for which women are not admitted to hospital. The prevalence of 
hypertension and diabetes was on the lower range of those reported in the literature. 30,31 
However, we would expect maternity HES data to capture significant acute morbidity such 
as VTE cases which are treated in secondary care in the UK.7,13 
 
Where gestation data were missing a multiple imputation was applied however we also 
conducted a sensitivity analysis excluding pregnancies of unknown length and results were 
similar to the original analysis. The amount of missing data for other variables was generally 
low apart from specific birth outcomes such as resuscitation and neonatal care. However, 
the sensitivity analysis showed unchanged results with a much lower missing value rate (2% 
missing for birthweight and 6.4% for SGA in the highest prevalence group). 
 We assessed HG readmission as a way of assessing severity, though we acknowledge that 
the probability of being readmitted could be influenced by other factors, such as external 
support or socio-cultural factors, not available from this data source.  
The current largest study on the topic,14 based on the Medical Birth Registry of Norway, a 
validated dataset for epidemiological research32, includes all births in Norway, compared 
with an estimated 97% of English births included in HES. The Norwegian study had 
information on maternal smoking, which is not available in HES, however, MBRN has been 
reported to underestimate cases of severe HG due to a codification change to less specific 
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codes for data recorded from 1999.33 It also does not include details such as onset an 
duration of HG.  It is likely that we have captured a good estimation of the starting time of 
this condition and a potential duration according to the dates of hospital admissions in the 
HES data. On the other hand, our study is based only on hospital admission for HG, which 
will skew the analysis towards the higher level of HG severity, excluding women who may 
only consult their GP or midwife, or obtain private support. 
 
Conclusions 
HG is associated with adverse health outcomes for the affected mother and child. Although 
for certain outcomes such as preeclampsia or VTE the absolute increased risks are low, HG 
can represent a warning sign of possible imminent complications, such as anaemia or 
dehydration. Recognition of early symptoms of HG and improvement in provision of timely 
support to women at high risk could help prevent and control complications such as 
anaemia, or VTE secondary to dehydration. Future research should assess effects of 
different treatments for HG offered in primary or secondary care settings on adverse 
pregnancy and birth outcomes, considering the low-quality evidence currently available.40 
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Supplemental Table 
Table S1 - Relative odds  of adverse outcomes for 4,757,713 live singletons births in women 
with HG admission and readmission and known gestational age at birth, between April 1997 
and March 2011. 
 
 Table 1 - Selected confounders for each outcome under analysis 
 
Outcomes: Adjusted for:
Antenatal Complications
Gestational Diabetes¹
Gestational Hypertension¹
Gestational Anaemia
Antenatal VTE
Pre-eclampsia
Perinatal complications
Placental dysfunction
Haemorrhage
Delivery factors
Induction of labour
Gestational week at delivery
Pregnancy outcome
Type of delivery
Delivery VTE 
Birth factors
Birth weight
SGA/LGA
Postnatal complications
Neonatal care
Resuscitation
Postnatal VTE² 
² Post-natal VTE was also adjusted for pregnancy outcome, 
induction of labour, gestational week at delivery and mode of 
delivery.
¹ Gestational diabetes or hypertension are not adjusted for the 
same pre-existing condition
Mutual indicates adjustment for other factors within the group 
(e.g. other antenatal complications)
Standard adjustments: maternal age, maternal ethnicity, socio-
economic status, year of delivery, region of treatments, parity, pre-
existing anaemia, pre-existing and gestational diabetes, pre-existing 
and gestational hypertension, hypercholesterolemia,  thyroid 
dysfunction, parathyroid dysfunction, sex of the baby and plurality
Standard & mutual
Standard & mutual
Standard 
Standard & mutual
Standard
Standard
Table 2 -Maternal characteristics for 8,211,850 pregnancies in women with hyperemesis 
gravidarum admission and readmission, between April 1997 and March 2011.
 
n % n % n %
Maternal age at delivery (years)
< 20 545,291 6.7 6,997 8.4 2,392 6.9
      20-24 1,515,108 18.7 21,981 26.3 8,700 25.2
25-29 2,187,967 27.0 25,298 30.2 10,992 31.8
30-34 2,334,278 28.8 19,458 23.3 8,290 24.0
35-39 1,245,589 16.4 8,245 9.9 3,492 10.1
      40-44 252,929 3.1 1,609 1.9 615 1.8
      ≥ 45 12,491 0.2 91 0.1 37 0.1
Maternal Ethnicityᵃ
White 5,579,842 68.9 51,768 61.9 19,986 57.9
Black and white 98,936 1.2 1,579 1.9 664 1.9
Asian 738,389 9.1 13,258 15.8 6,721 19.5
Black 384,520 4.8 8,101 9.7 3,600 10.4
Chinese 41,296 0.5 221 0.3 85 0.3
Other 168,194 2.1 1,867 2.2 805 2.3
missing 1,082,476 13.4 6,885 8.2 2,657 7.7
Maternal socio-economic status
1 (least deprivation) 1,305,784 16.1 9,465 11.3 3,694 10.7
2 1,328,418 16.4 10,775 12.9 4,318 12.5
3 1,461,670 18.1 13,738 16.4 5,489 15.9
4 1,728,277 21.4 18,903 22.6 7,813 22.6
5 (most deprivation) 2,216,406 27.4 30,415 36.4 13,049 37.8
missing 53,098 0.7 383 0.5 155 0.5
Multiple delivery
singleton 7,932,988 98.0 81,086 96.9 33,230 96.3
twins 121,083 1.5 2,184 2.6 1,102 3.2
triplets and more 5,613 0.1 95 0.1 61 0.2
unknown 33,969 0.4 314 0.4 125 0.4
Sex of the baby
Male 3,868,562 47.8 35,988 43.0 14,243 41.3
Female 3,814,614 47.1 42,613 50.9 18,112 52.5
not sepcified 8,663 0.1 64 0.1 29 0.1
Multiple males 26,352 0.3 436 0.5 203 0.6
Multiple mixed 34,577 0.4 614 0.7 322 0.9
Multiple females 26,027 0.3 490 0.6 264 0.8
missing 314,858 3.9 3,474 4.2 1,345 3.9
Parityᵇ 
0 4,231,003 52.3 42,975 51.4 17,479 50.6
≥1 3,862,650 47.7 40,704 48.6 17,039 49.4
Pre-existing Anaemiaᶜ 391,268 4.8 5,783 6.9 2,787 8.1
Pre-existing Diabetesᶜ
type 1 29,072 0.4 580 0.7 245 0.7
type 2 8,968 0.1 107 0.1 50 0.1
unspecified 17,026 0.2 136 0.2 75 0.2
Pre-existing Hypertensionᶜ
pre-existing 28,942 0.4 299 0.4 120 0.4
unspecified 241,491 3.0 2,859 3.4 1,189 3.4
Thyroid dysfunctionᶜ 46,619 0.6 802 1.0 482 1.4
Parathyroid dysfunctionᶜ 255 <0.01 11 0.0 10 <0.01
Hypercholesterolaemiaᶜ 1,085 <0.1 31 0.0 20 0.1
ᶜ Diagnosis recorded at any admission during the current pregnancy. For pre-existing anaemia only diagnoses recorded up to the end of the first trimester 
were considered
Pregnancies in women with
HG = Hyperemesis Gravidarum.  Pregnancies are defined as HG admisson if there was only one hospital admission with primary diagnosis of HG in the 
current pregnancy or HG readmission if there was more than one hospital admission in the current pregnancy.
ᵇ Parity defined as combination of diagnostic codes information, original HES variable and number of previous recorded deliveries. 
Maternal characteristics
no HG admission                        
N= 8,093,653 
ᵃCategories reflect HES definitions: Asian includes Indian, Pakistani, Bangladeshi and other Asian ethnicity other than Chinese
 HG admission                            
N=  83,679
HG readmission                             
N=34,518
 HG admission HG readmission
n % n % n % aOR (99% CI) aOR (99% CI)
Gestational Anaemia
None 7,704,232 95.2 78,087 93.3 31,857 92.3
Present 389,421 4.8 5,592 6.7 2,661 7.7 1.28 (1.23, 1.33) 1.43 (1.35, 1.51)
Gestational Diabetes
None 7,916,410 97.8 81,528 97.4 33,582 97.3
Present 122,177 1.5 1,328 1.6 566 1.6 0.96 (0.89, 1.03) 0.91 (0.82, 1.02)
Gestational Hypertensionᵃ
None 7,583,268 93.7 77,902 93.1 31,926 92.5
Present 239,952 3.0 2,619 3.1 1,283 3.7 1.08 (1.03, 1.14) 1.27 (1.18, 1.37)
Preeclampsia 
None 7,911,740 97.8 81,381 97.3 33,448 96.9
Preeclampsia 180,853 2.2 2,275 2.7 1,062 3.1 1.16 (1.09, 1.22) 1.27 (1.17, 1.39)
Eclampsia 1,060 <0.1 23 <0.1 8 <0.1 1.84 (1.07, 3.18) 1.50 (0.60, 3.76)
VTE antepartum 
None 8,083,232 99.9 83,444 99.7 34,394 99.6
Deep vein thrombosis 7,572 0.1 155 0.2 88 0.3 1.94 (1.57, 2.39) 2.64 (2.00, 3.48)
Pulmonary Embolism 2,849 <0.1 80 0.1 36 0.1 2.54 (1.89, 3.40) 2.69 (1.75, 4.15)
VTE at delivery 
None 8,091,250 99.9 83,629 99.9 34,493 99.9
Deep vein thrombosis 1,771 <0.1 38 0.1 15 <0.1 2.11 (1.37, 3.26) 2.00 (1.03, 3.92)
Pulmonary Embolism 632 <0.1 12 <0.1 10 <0.1 1.75 (0.82, 3.71) 3.47 (1.53, 7.89)
VTE at delivery  with no prior antepartum VTE
None 8,081,640 99.9 83,418 99.9 34,381 99.9
Deep vein thrombosis 1,139 <0.1 20 <0.1 6 <0.1 1.74 (0.97, 3.12) 1.24 (0.43, 3.56)
Pulmonary Embolism 453 <0.1 6 <0.1 7 <0.1 1.21 (0.42, 3.49) 3.36 (1.25, 8.98)
VTE 12 weeks postpartum   
None 8,087,784 99.9 83,584 99.9 34,472 99.9
Deep vein thrombosis 3,356 <0.1 51 0.1 24 0.1 1.49 (1.03, 2.14) 1.69 (0.99, 2.86)
Pulmonary Embolism 2,513 <0.1 44 0.1 22 0.1 1.61 (1.08, 2.38) 1.92 (1.11, 3.34)
VTE 12 weeks postpartum  with no prior VTE antepartum or at delivery
None 8,076,197 99.9 83,332 99.9 34,346 99.9
Deep vein thrombosis 3,088 <0.1 48 0.1 18 0.1 1.54 (1.05, 2.24) 1.39 (0.75, 2.55)
Pulmonary Embolism 2,355 <0.1 38 0.1 17 0.1 1.50 (0.98, 2.28) 1.61 (0.86, 3.01)
CI= confidence interval
1.00 (Reference)
1.00 (Reference)
1.00 (Reference)
HG = Hyperemesis Gravidarum.  Pregnancies are defined as HG admisson if there was only one hospital admission with primary diagnosis of HG in the current pregnancy or HG readmission if there 
was more than one hospital admission in the current pregnancy.
aOR= adjusted conditional odds ratio from multinomial logistic regression other than for gestational anaemia, diabetes and hypertension where binary logistic regression was used; see Table 1 for 
model covariate adjustments. Baseline comparions for all models are pregnancies with no HG admission.
ᵃ  Not adjusted for hypercholesterolaemia due to lack of variability
Table 3 -Adverse maternal outcomes for  8,211,850 pregnancies in women with hyperemesis gravidarum admission and 
readmission, between April 1997 and March 2011. 
Maternal outcomes
Pregnancy in women with
no HG admission 
N=8,093,653  
 HG admission                             
N=  83,679
HG readmission                             
N=  34,518  
Odds ratios of adverse outcomes in 
women with
1.00 (Reference)
1.00 (Reference)
1.00 (Reference)
1.00 (Reference)
1.00 (Reference)
1.00 (Reference)
  HG admission HG readmission     
n % n % n % aOR (99% CI) aOR (99% CI)
Haemorrhage at delivery
None 7,264,425 89.8 75,143 89.8 31,035 89.9
Ante-partum 116,528 1.4 1,274 1.5 483 1.4 1.08 (0.99, 1.17) 1.00 (0.88, 1.14)
Intra-partum 126,660 1.6 1,173 1.4 470 1.4 0.93 (0.87, 1.01) 0.89 (0.79, 1.00)
Post-partum 586,040 7.2 6,089 7.3 2,530 7.3 0.95 (0.92, 0.99) 0.93 (0.88, 0.99)
Placental dysfunctionsᵃ 
None 7,930,210 98.0 82,110 98.1 33,880 98.2
 Malformation 85,849 1.1 771 0.9 326 0.9 0.93 (0.85, 1.02) 0.97 (0.84, 1.12)
 Previa 48,032 0.6 458 0.6 166 0.5 0.99 (0.87, 1.13) 0.88 (0.70, 1.10)
 Abruption 29,562 0.4 340 0.4 146 0.4 1.08 (0.93, 1.24) 1.11 (0.90, 1.38)
Induction of Labour
None 4,112,131 50.8 40,850 48.8 16,867 48.9
Surgical only 970,265 12.0 10,914 13.0 4,509 13.1 1.10 (1.07, 1.13) 1.13 (1.08, 1.18)
Medical only 949,439 11.7 9,862 11.8 3,978 11.5 1.08 (1.05, 1.11) 1.09 (1.04, 1.14)
Surgical and medical 1,049,463 13.0 12,771 15.3 5,478 15.9 1.20 (1.16, 1.23) 1.29 (1.23, 1.34)
Other/ unspecified 14,630 0.2 144 0.2 60 0.2 1.22 (0.98, 1.51) 1.28 (0.91, 1.79)
Unknown 997,725 12.3 9,138 10.9 3626 10.5 1.00 (0.97, 1.03) 0.99 (0.95, 1.05)
Pregnancy outcome
Live birth(s) 8,050,475 99.5 83,277 99.5 34,332 99.5
Stillbirth(s) 39,443 0.5 355 0.4 157 0.5 0.77 (0.66, 0.89) 0.82 (0.66, 1.01)
Live birth and Stillbirthᵇ 3,735 0.1 47 0.1 29 0.1 0.97 (0.66, 1.43) 1.20 (0.73, 1.99)
Type of delivery
Spontateous 5,177,860 64.0 53,640 64.1 22,022 63.8
Emergency C-Section 1,189,153 14.7 12,670 15.1 5,314 15.4 1.01 (0.98, 1.04) 0.97 (0.92, 1.03)
Elective C-Section 725,164 9.0 7,192 8.6 2,921 8.5 1.12 (1.08, 1.16) 1.07 (0.99, 1.16)
Assisted 958,641 11.8 9,674 11.6 4,044 11.7 1.02 (0.99, 1.05) 1.02 (0.95, 1.09)
Breech 42,835 0.5 503 0.6 217 0.6 1.04 (0.92, 1.17) 1.04 (0.81, 1.35)
CI= confidence interval
ᵇ at least one live birth and one stillbirth
Table 4 -Adverse delivery outcomes for  8,211,850 pregnancies in women with hyperemesis gravidarum admission and 
readmission, between April 1997 and March 2011.
ᵃ Diagnosis recorded at delivery admission and mutually exclusive
Pregnancy in women with
HG = Hyperemesis Gravidarum.  Pregnancies are defined as HG admisson if there was only one hospital admission with primary diagnosis of HG in the current pregnancy or HG readmission if there was 
more than one hospital admission in the current pregnancy.
Delivery outcomes
Odds ratios of adverse outcomes in 
women with
1.00 (Reference)
1.00 (Reference)
aOR= adjusted conditional odds ratio from multinomial logistic regression; see Table 1 for model covariate adjustments. Baseline comparions for all models are pregnancy with no HG admission.
no HG admissions                         
N=8,093,653
HG admission                             
N=  83,679
HG readmission                             
N= 34,518  
1.00 (Reference)
1.00 (Reference)
1.00 (Reference)
 HG admission HG readmission
n % n % n % aOR (99% CI) aOR (99% CI)
Gestational week at birth
<32 30,285 0.5 431 0.6 171 0.6 1.18 (1.05, 1.32) 1.16 (0.96, 1.39)
32-36 235,562 3.5 2,926 4.3 1,357 4.8 1.11 (1.05, 1.17) 1.19 (1.09, 1.28)
37-41 4,206,797 62.4 44,341 64.4 18,485 65.3
≥42 214,804 3.2 1,882 2.7 672 2.4 0.90 (0.85, 0.96) 0.81 (0.73, 0.90)
Missing 2,050,444 30.4 19,278 28.0 7,625 26.9
Birth weight of singletons
<2500 gr 312,276 4.6 4,087 5.9 2,004 7.1 1.12 (1.08, 1.17) 1.30 (1.22, 1.38)
2500-4000 gr 4,471,198 66.4 47,796 69.4 19,719 69.7
 ≥4000 gr 627,045 9.3 5,147 7.5 1,955 6.9 0.88 (0.85, 0.91) 0.83 (0.78, 0.88)
unknown 1,327,373 19.7 11,828 17.2 4,632 16.4 0.95 (0.93, 0.99) 0.92 (0.88, 0.96)
SGA/LGA
normal 3,290,224 48.8 35,427 51.5 14,827 52.4
sga 393,594 5.8 5,202 7.6 2,460 8.7 1.06 (1.01, 1.11) 1.13 (1.07, 1.20)
lga 704,297 10.5 6,408 9.3 2,473 8.7 0.97 (0.93, 1.00) 0.92 (0.87, 0.98)
Missing 2,349,777 34.9 21,821 31.7 7,625 26.9
Resuscitation methodᵇ 
none 3,727,988 55.3 37,954 55.1 15,873 56.1
drugs 136,910 2.0 1,645 2.4 645 2.3 1.13 (1.05, 1.21) 1.03 (0.92, 1.15)
mask 273,953 4.1 2,893 4.2 1,188 4.2 1.09 (1.04, 1.14) 1.06 (0.98, 1.15)
drugs and mask 44,086 0.7 545 0.8 221 0.8 1.19 (1.06, 1.33) 1.13 (0.94, 1.34)
tube 30,532 0.5 296 0.4 129 0.5 1.06 (0.91, 1.23) 1.09 (0.87, 1.37)
tube and drugs 14,098 0.2 128 0.2 61 0.2 0.97 (0.77, 1.22) 1.12 (0.80, 1.55)
unknown 2,510,325 37.3 25,397 36.9 10,193 36.0 1.06 (1.03, 1.08) 1.03 (0.99, 1.07)
Neonatal careᶜᵈ 
normal 4,771,428 70.8 48,159 69.9 19,664 69.5
special care 362,677 5.4 4,283 6.2 1,845 6.5 1.14 (1.09, 1.18) 1.18 (1.11, 1.26)
intensive care 36,345 0.5 440 0.6 146 0.5 1.18 (1.04, 1.33) 0.93 (0.75, 1.16)
very intensive care 54,146 0.8 665 1.0 299 1.1 1.16 (1.05, 1.28) 1.22 (1.05, 1.42)
unknown 1,513,296 22.5 15,311 22.2 6,356 22.5 0.98 (0.96, 1.01) 0.99 (0.96, 1.04)
CI= confidence interval
ᵉ Missing values for these variables are estimated in the regression models using multiple imputation, therefore no OR is given.
ᵃ only live children matched to their mothers.
Table 5 - Relative odds of adverse outcomes for 6,835,060 live singletons births in women with HG admission and 
readmission, between April 1997 and March 2011.
no HG admission                        
N=  6,737,892
Live singleton birthsᵃ in women with
Birth  outcomes HG admission                             
N= 68,858
HG readmission                            
N=  28,310 
1.00 (Reference)
ᵉ
Odds ratios of adverse outcomes in 
women with
ᵈ The HG analysis is not adjusted for diabetes due to lack of variability
ᵇ The HG analysis is not adjusted for hypercholesterolemia, diabetes and parathyroid dysfunction due to lack of variability
ᶜ Neonatal level of care according to HES definition 
aOR= adjusted conditional odds ratio from multinomial logistic regression; see Table 1 for model covariate adjustments. Baseline comparions for all models are pregnancy with no HG 
admission.
1.00 (Reference)
HG = Hyperemesis Gravidarum.  Pregnancies are defined as HG admisson if there was only one hospital admission with primary diagnosis of HG in the current pregnancy or HG 
readmission if there was more than one hospital admission in the current pregnancy.
1.00 (Reference)
1.00 (Reference)
1.00 (Reference)
ᵉ
  HG admission HG readmission     
n % n % n % aOR (99% CI) aOR (99% CI)
Gestational week at birth
<32 30,285 0.7 431 0.9 171 0.8 1.30 (1.14, 1.47) 1.28 (1.05, 1.57)
32-36 235,562 5.0 2,926 5.9 1,357 6.6 1.15 (1.09, 1.21) 1.30 (1.21, 1.40)
37-41 4,206,797 89.8 44,341 89.4 18,485 89.4
≥42 214,804 4.6 1,882 3.8 672 3.3 0.81 (0.76, 0.86) 0.69 (0.62, 0.77)
Birth weight of singletons
<2500 gr 253,169 5.4 3,384 6.8 1,674 8.1 1.13 (1.08, 1.19) 1.31 (1.22, 1.40)
2500-4000 gr 3,807,676 81.2 41,027 82.8 17,082 82.9
 ≥4000 gr 533,093 11.4 4,419 8.9 1,652 8.0 0.88 (0.84, 0.92) 0.81 (0.76, 0.87)
unknown 93,510 2.0 750 1.5 277 1.3 0.92 (0.84, 1.02) 0.82 (0.70, 0.97)
SGA/LGA
normal 3,290,224 70.2 35,427 71.5 14,827 71.7
sga 393,594 8.4 5,202 10.5 2,460 11.9 1.07 (1.03, 1.11) 1.16 (1.10, 1.23)
lga 704,297 15.0 6,408 12.9 2,473 12.0 0.95 (0.91, 0.98) 0.89 (0.84, 0.94)
unknown 299,333 6.4 2,543 5.1 925 4.5 0.86 (0.82, 0.91) 0.76 (0.69, 0.83)
Resuscitation methodᵇ 
none 3,223,667 68.8 33,347 67.3 14,076 68.1
drugs 119,326 2.6 1,483 3.0 592 2.9 1.14 (1.06, 1.22) 1.05 (0.93, 1.17)
mask 234,215 5.0 2,521 5.1 1,048 5.1 1.09 (1.03, 1.15) 1.07 (0.98, 1.16)
drugs and mask 37,642 0.8 484 1.0 198 1.0 1.21 (1.07, 1.36) 1.15 (0.95, 1.38)
tube 25,534 0.5 251 0.5 108 0.5 1.06 (0.90, 1.26) 1.08 (0.83, 1.38)
tube and drugs 12,230 0.3 111 0.2 48 0.2 0.97 (0.76, 1.24) 1.01 (0.70, 1.47)
unknown 1,034,834 22.1 11,383 23.0 4,615 22.3 1.09 (1.06, 1.12) 1.07 (1.02, 1.12)
Neonatal careᶜᵈ 
normal 3,454,494 73.7 35,921 72.5 14,852 71.8
special care 272,985 5.8 3,365 6.8 1,497 7.2 1.16 (1.10, 1.21) 1.23 (1.14, 1.32)
intensive care 26,298 0.6 331 0.7 110 0.5 1.21 (1.05, 1.40) 0.95 (0.75, 1.22)
very intensive care 38,973 0.8 498 1.0 220 1.1 1.18 (1.05, 1.33) 1.22 (1.02, 1.46)
unknown 894,698 19.1 9,465 19.1 4,006 19.4 0.98 (0.95, 1.01) 0.99 (0.95, 1.05)
ᶜ Neonatal level of care according to HES definition 
HG = Hyperemesis Gravidarum.  Pregnancies are defined as HG admisson if there was only one hospital admission with primary diagnosis of HG in the current pregnancy or HG readmission 
if there was more than one hospital admission in the current pregnancy.
aOR= adjusted conditional odds ratio from multinomial logistic regression; see Table 1 for model covariate adjustments. Baseline comparions for all models are pregnancy with no HG 
admission.
CI= confidence interval
ᵈ The HG analysis is not adjusted for diabetes due to lack of variability
1.00 (Reference)
1.00 (Reference)
ᵃ only live children matched to their mothers.
ᵇ The HG analysis is not adjusted for hypercholesterolemia, diabetes and parathyroid dysfunction due to lack of variability
1.00 (Reference)
1.00 (Reference)
Table S1 - Relative odds of adverse outcomes for 4,757,713 live singletons births in women with HG admission and 
readmission and known gestational age at birth, between April 1997 and March 2011.
1.00 (Reference)
Birth  outcomes  HG admission                             
N= 49,580
HG readmission                             
N=  20,685  
Odds ratios of adverse outcomes in 
women with
Live singleton birthsᵃ  in women with
no HG admission                       
N=4,687,448   
